Browsing: Medication & Drugs

Press Release – Roche’s Tecentriq® SC (atezolizumab) becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Singapore, reducing treatment time to a few minutes

By 0
Roche announced today that Tecentriq® SC (atezolizumab) has been approved by the Singapore Health Sciences Authority (HSA) for all indications in which the intravenous (IV) formulation of Tecentriq has been previously approved, including certain types of lung, breast and liver cancer.4 Tecentriq SC is Roche’s fourth subcutaneous cancer therapy,5-7 and the world’s first injectable anti-PD-(L)1 cancer immunotherapy.

Log In or Register as a healthcare professional to read the full article.

Ozempic Updates: It Provides Kidney Health Benefits and Creates Accidental Babies?

By 0

The weight-loss drug Ozempic is well-known for its effectiveness in managing type 2 diabetes and aiding significant weight loss. Additionally, it has recently been linked to unexpected pregnancies and new health benefits. Several women reported surprise pregnancies after using the drug. Concurrently, recent studies also suggest Ozempic could reduce the risk of kidney disease progression in diabetic patients.